Zinc supplementation as an adjunct to antibiotics in the treatment of pneumonia in children 2 to 59 months of age

Read full article

There is insufficient evidence from randomised controlled trials (RCTs) to support the use of zinc as an adjunct to antibiotics in the treatment of pneumonia in children aged between 2 and 59 months.

Acute respiratory infections particularly pneumonia, are responsible for high mortality in low income countries among children aged between 2 and 59 months. The evidence for the use of zinc as an adjunct to antibiotics in the treatment of pneumonia is rather varied. The aim of the systematic review was to evaluate zinc supplementation as an adjunct to antibiotics in the treatment of (clinical recovery) pneumonia in children aged between 2 and 59 months.

Add yours ↓

Comments are closed.